baber/WOPTO huggingface dataset:
Patent EP-4034945-A1 (EP)
Inventor: KAMI HIDETOSHI
IPC: G03G5/05
Filed: 2020-07-21
Abstract: L'invention concerne un dispositif électronique comprenant : un support ; une couche de transport de charge comprenant un matériau de transport de charge, ou une couche d'électrode de colorant sensibilisateur comprenant un colorant sensibilisateur, la couche de transport de charge ou la couche d'électrode de colorant sensibilisateur étant disposée sur ou au-dessus du support ; et une couche d'oxyde métallique disposée sur ou au-dessus de la couche de transport de charge ou de la couche d'électrode de colorant sensibilisateur, la couche d'oxyde métallique comprenant de l'oxyde métallique semi-conducteur de type p et de la silice ou des particules d'oxyde métallique, et une quantité de la silice ou des particules d'oxyde métallique incluses dans la couche d'oxyde métallique étant supérieure ou égale à 0,5 % en masse mais inférieure ou égale à 1,5 % en masse par rapport à la couche d'oxyde métallique.
Patent EP-3899700-A1 (EP)
Title: Dispositif électronique pliable permettant de commander une interface utilisateur et son procédé de fonctionnement
Inventor: LEE SUKJAE
IPC: G06F1/16
Filed: 2020-02-19
Abstract: L'invention concerne un dispositif électronique pliable qui commande une UI et un procédé de fonctionnement de celui-ci. Un dispositif électronique comprend un premier boîtier comprenant une première face et une deuxième face opposée à la première face ; un second boîtier comprenant une troisième face et une quatrième face opposée à la troisième face ; une charnière reliant le premier boîtier et le second boîtier, le second boîtier se repliant autour de la charnière pour faire face au premier boîtier ; un écran flexible s'étendant de la première face à la troisième face ; un circuit de capteur configuré pour détecter un angle formé par le premier boîtier et le second boîtier se pliant au niveau de la charnière ; et un processeur connecté de manière fonctionnelle à l'écran flexible et au circuit de capteur. Le processeur est configuré pour détecter un état physique du premier boîtier et du second boîtier sur la base du circuit de capteur et pour ré-exécuter une application actuellement exécutée lorsque l'état physique détecté change. L'état physique comprend un premier état dans lequel le premier boîtier et le second boîtier sont pliés l'un sur l'autre ou un second état dans lequel la première face du premier boîtier et la troisième face du second boîtier font face à une même direction.
Patent EP-3927151-A1 (EP)
Inventor: RÖDDING THOMAS
IPC: G09F3/08
Filed: 2020-02-19
Abstract: A system for recording and tracking the processing of an object, such as a killed game animal, or other kind of object. An origin tag has a unique identifier and is attached to the object to be documented and recorded. A database maintains a central registry of the unique identifiers that have been issued on origin tags. The identifiers are disbursed to separate mobile devices, typically smart phones, allowing the user to update information to specific origin tags, without having an Internet connection to the central registry. The data stored on the separate mobile devices are integrated into the central registry, so as to create a complete registry of the unique identifiers, along with the updated information recorded for each of those identifiers
Patent EP-3927718-A1 (EP)
Inventor: O'CARROLL COLIN
IPC: C12P21/08
Filed: 2020-02-20
Abstract: Described herein is the use of PPAR6 agonists in the treatment of mitochondrial myopathy. In one aspect, described herein are methods for treating a primary mitochondrial myopathy (PMM) in a mammal comprising administering to the mammal with a primary mitochondrial myopathy a peroxisome proliferator-activated receptor delta (PPAR6) agonist compound. In another aspect, described herein is a method of modulating PPAR6 in a mammal with primary mitochondrial myopathy comprising administering to the mammal with primary mitochondrial myopathy PPAR6 agonist compound.
Patent EP-4013506-A1 (EP)
Title: Protéines de liaison à 4-1bb et ox40 et compositions et méthodes associées, anticorps dirigés contre 4-1bb, anticorps dirigés contre ox40
Inventor: BIENVENUE DAVID LEONARD
IPC: A61P35/00
Filed: 2020-08-12
Abstract: La présente invention concerne des anticorps qui se lient spécifiquement à 4-1BB et/ou OX40, comprenant des anticorps bispécifiques qui se lient à 4-1BB et OX40, et des compositions comprenant de tels anticorps. L'invention concerne également des méthodes de traitement de troubles, tels que le cancer, à l'aide de tels anticorps et de telles compositions.
Patent EP-4018587-A1 (EP)
Inventor: MANOLAKOS ALEXANDROS
IPC: H04L5/00
Filed: 2020-08-19
Abstract: Des aspects de la présente invention se rapportent à la communication sans fil. Selon certains aspects, un équipement utilisateur (UE) peut recevoir une configuration (505) qui indique une association entre un ensemble de ressources de signal de référence de sondage (SRS) et une ressource de signal de référence (RS) de liaison descendante (DL) à utiliser pour déterminer une propriété de transmission d'un ou de plusieurs SRS dans l'ensemble de ressources de SRS, la ressource de signal de référence de liaison descendante étant associée à un premier ensemble de ports à utiliser pour effectuer une mesure de la ressource de signal de référence de liaison descendante. L'UE peut déterminer (510) la propriété de transmission du ou des SRS dans l'ensemble de ressources SRS à l'aide de moins de ports plutôt qu'un certain nombre de ports inclus dans le premier ensemble de ports, sur la base, au moins en partie, d'une détermination que l'UE fonctionne dans un mode d'économie d'énergie. L'UE peut transmettre (520) le ou les SRS à l'aide de la propriété de transmission. L'invention porte également sur d'autres aspects.
Patent EP-3938353-A1 (EP)
Inventor: HUSSEIN ISLAM
IPC: C07D239/72
Filed: 2020-03-12
Abstract: The present invention is related to the discovery of a combination therapy for the treatment or prevention of cytomegalovirus infection.in humans and other mammals, comprising the administration of a synergistic therapeutic effective amount of both fiiociclovir and letermovir.
Patent EP-3940000-A1 (EP)
Inventor: SEO HONG SEOG
IPC: G01N33/58
Filed: 2020-03-13
Abstract: A carrageenan derivative according to the present disclosure can quickly and easily detect and label the presence of inflammation-related macrophages and, particularly, can accurately and easily identify M1-type macrophages highly associated with early inflammation. In addition, the carrageenan derivative has advantages in that it can be produced easily, environmental pollution is minimized because a small amount of organic solvent is used, and initial cost is low.
Patent EP-4021271-A1 (EP)
Inventor: PLESS BENJAMIN D
IPC: A61B/
Filed: 2020-08-31
Abstract: An opioid overdose rescue device is provided that includes an ingestible capsule. Within the ingestible capsule is a non-refillable drug dispenser comprising an opioid antidote and at least one sensor configured to detect at least one physiological parameter indicative of an opioid overdose. A controller is also contained within the ingestible capsule and is operatively coupled to the drug dispenser and the least one sensor. The controller is configured to receive a signal detected by the least one sensor of the at least one physiological parameter to actuate release of the opioid antidote from the drug dispenser into the intestine of the patient upon a determination that the at least one physiological parameter falls outside a threshold value or range for the at least one physiological parameter indicating that an opioid overdose has been detected.
Patent EP-3943621-A1 (EP)
Inventor: KAWAMURA TAKASHI
IPC: C22C38/58
Filed: 2020-03-17
Abstract: A base metal for clad steel contains: in terms of mass%, C: 0.04% to 0.10%, Si: 0.10% to 0.30%, Mn: 1.30% to 1.60%, P: 0.015% or less, S: 0.005% or less, Ni: 0.10% to 0.50%, Cr: 0.10% or less, Cu: 0.05% or less, Mo: 0.05% to 0.40%, V: 0.02% to 0.06%, Nb: 0.03% or less, Ti: 0.005% to 0.025%, Al: 0.020% to 0.050%, N: 0.0030% to 0.0100%, and the balance being Fe and unavoidable impurities. In the composition, a carbon equivalent Ceq according to the following formula (1) Ceq = C + Mn/6 + (Ni + Cu)/15 + (Cr + Mo + V)/5 (mass%) is 0.400 or less, and a yield ratio Y.R. according to the following formula (2) Y.R. = Y.S. (MPa; 0.5% Under load)/T.S. (MPa) is less than 0.80.
Patent EP-4171748-A1 (EP)
Inventor: BADOVINAC-CRNJEVIC TANJA
IPC: A61K39/395
Filed: 2020-09-11
Abstract: La demande divulgue une association à dose fixe (FDC) de pertuzumab, de trastuzumab et éventuellement de hyaluronidase humaine recombinante (rHuPH20), qui est administrée aux patients par voie sous-cutanée. L'invention concerne et revendique l'efficacité finale et les données de sécurité de l'essai clinique FeDeriCa, des procédés d'information posologique pour les États-Unis (USPI) (y compris pour usage domestique), et l'analyse primaire de l'essai clinique PHranceSCa.
Patent EP-4048816-A1 (EP)
Title: Molécules hla de classe i dans la fécondation in vitro et d'autres implications médicales
Inventor: WÜRFEL WOLFGANG
IPC: A61K31/7088
Filed: 2020-10-19
Abstract: La présente invention concerne une molécule d'acide nucléique, un vecteur, une cellule hôte, ou une protéine ou un peptide, ou toute combinaison de ces derniers pour une utilisation dans un procédé d'augmentation de l'efficacité d'implantation embryonnaire dans un programme de fertilisation  in vitro , (I) ladite au moins une molécule d'acide nucléique étant choisie parmi des molécules d'acide nucléique (a) codant pour un polypeptide HLA-H, HLA-G, HLA-J, HLA-L, HLA-V, HLA-Y, HLA-E, HLA-F ou un polypeptide qui est identique à au moins 85 %, ou consiste en un fragment de la molécule d'acide nucléique comprenant au moins 150 nucléotides ; et le procédé d'augmentation de l'efficacité d'implantation embryonnaire comprenant (i) la mise en contact de la molécule d'acide nucléique, du vecteur, de la cellule hôte, ou de la protéine ou du peptide, ou toute combinaison de ces derniers avec l'ovocyte fécondé, fertilisé et/ou l'embryon de préimplantation avant le transfert de l'ovocyte fécondé ou de l'embryon de préimplantation dans l'utérus ; ou (ii) avant, simultanément avec et/ou après le transfert de l'ovocyte fécondé ou de l'embryon de préimplantation à l'utérus; ou (iii) l'administration systémique de la molécule d'acide nucléique, du vecteur, de la cellule hôte, ou de la protéine ou du peptide.
Patent EP-3959317-A1 (EP)
Inventor: RO SEUNGIL
IPC: A61K31/7115
Filed: 2020-04-24
Abstract: The present invention relates to methods and compositions comprising a miR-10a-5p or miR-10b-5p mimic for treatment of gastrointestinal motility disorders, obesity and diabetes.
Patent EP-4065915-A1 (EP)
Title: Heat transfer plate
Inventor: NORÉN MATTIAS
IPC: F28F3/04
Filed: 2020-11-04
Abstract: A heat transfer plate (8) for a plate heat exchanger (2) is provided. It comprises a heat transfer area (22) provided with a heat transfer pattern. The heat transfer pattern comprises elongate alternately arranged heat transfer ridges and heat transfer valleys (36, 38), a respective top portion (40) of the heat transfer ridges (36) extending in a top plane (T) and a respective bottom portion (42) of the heat transfer valleys (38) extending in a bottom plane (B). The heat transfer ridges (36) comprise ridge contact areas (52, 62) within which the heat transfer ridges (36) are arranged to abut an adjacent first heat transfer plate (48) in the plate heat exchanger (2), and the heat transfer valleys (38) comprise valley contact areas (54, 64) within which the heat transfer valleys (38) are arranged to abut an adjacent second heat transfer plate (50) in the plate heat exchanger (2). Within at least half of the heat transfer area (22), the top portions (40) of the heat transfer ridges (36) have a first width w1, and the bottom portions (42) of the heat transfer valleys (38) have a second width w2, w1≠w2. The heat transfer plate (8) is characterized in that the top portion (40) of a number of first heat transfer ridges (36a, 36b) of the heat transfer ridges (36), within a respective first ridge contact area (52a, 62b) of the ridge contact areas (52, 62), has a third width w3, wherein, if w1>w2 then w3<w1, and, if w1<w2 then w3>w1.
Patent EP-3894985-A1 (EP)
Inventor: HEO JIHUN
IPC: G06F1/16
Filed: 2020-05-07
Abstract: An electronic device includes a display module including: a housing; a display including a first panel including a first surface, a second surface opposite the first surface, and a plurality of pixels interposed between the first surface and the second surface; a cover layer disposed on the first surface of the first panel; a second panel disposed on the second surface of the first panel; and a sensor coupled to the second surface of the first panel to provide a sensing area on the one surface of the housing.
Patent EP-4061203-A1 (EP)
Inventor: VAN KESTEREN HANS WILLEM
IPC: A61B5/00
Filed: 2020-11-13
Abstract: The invention provides a method for obtaining a filtered capnography signal by suppressing a spectral background signal within an optical absorption signal. An optical absorption signal is obtained from a subject across a range of wavelengths, wherein the optical absorption signal represents a proportion of a light signal that is absorbed as the light signal passes through a respiratory air sample undergoing investigation, and wherein the optical absorption signal comprises a spectral background signal. A second harmonic signal is isolated from the optical absorption signal and the period of the spectral background signal is identified. The second harmonic signal is sampled at a central wavelength of the second harmonic signal, wherein the central wavelength represents a maximum Carbon Dioxide absorption, an at an off-center wavelength of the second harmonic signal, wherein the off-center wavelength and the central wavelength are separated by a multiple of the period of the spectral background signal. A filtered capnography signal is then generated based on the sampled second harmonic signal.
Patent EP-3971527-A1 (EP)
Inventor: YOSHIZAWA ATSUSHI
IPC: G01C21/34
Filed: 2020-05-07
Abstract: The present disclosure relates to an information processing apparatus, and an information processing method, and a program that allow travelable areas to be appropriately selected according to performances, functions, and types of sensors that a vehicle includes, to realize appropriate automatic driving while avoiding critical states. 
     Traveling possibility or impossibility information of every sensor category set according to types and performances of sensors with which vehicles are equipped, of a path of every area is acquired, and it is determined whether or not a route to a destination is most appropriate, on the basis of the sensor category of an own car, and the traveling possibility or impossibility information. If the route is not most appropriate, replanning is performed. The present disclosure can be applied to mobile bodies.
Patent EP-4045662-A1 (EP)
Inventor: WEIN NICOLAS SEBASTIEN
IPC: C12N15/85
Filed: 2020-10-19
Abstract: The disclosure provides gene therapy vectors, such as adeno-associated virus (AAV), designed for treatment of an Interferon regulatory factor 2 binding protein like (IRF2BPL) disorder.
Patent EP-4065883-A1 (EP)
Inventor: JARS BLAISE
IPC: F21W102/155
Filed: 2020-11-27
Abstract: The invention relates to a light module (101), in particular for a motor vehicle, comprising a light source (104) capable of emitting light beams; a reflection surface (102.2) intended to be covered with a varnish and configured to reflect the light beams in such a way as to form a light beam with an upper cut-off, the reflection surface comprising a first zone (102.2.4, 102.2.6) extending longitudinally and configured to form a light image with an upper cut-off and a second zone (102.2.3, 102.2.5) and a third zone (102.2.5, 102.2.7) extending longitudinally along the first zone (102.2.4, 102.2.6), respectively to either side of the first zone, in which the reflection surface (102.2) has a transverse profile forming a downward step from the first zone (102.2.4, 102.2.6) to each of the second (102.2.3, 102.2.5) and third (102.2.5, 102.2.7) zones.
Patent EP-3976969-A1 (EP)
Inventor: MCCULLOUGH ANDREW CLAY
IPC: F04D1/06
Filed: 2020-05-28
Abstract: A vertical pump features stationary bowl assembly, a rotating power transmission shaft, impellers and bottom wear-ring bearings. The stationary bowl assembly includes bowls, each bowl having a respective bowl bottom inside surface. The rotating power transmission shaft is configured to extend through the stationary bowl assembly. The impellers are arranged on the rotating power transmission shaft to rotate and draw material through the stationary bowl assembly, each impeller having a respective impeller bottom outside surface. Each bottom wear-ring bearing is arranged between the respective impeller bottom outside surface of each impeller and the respective bowl bottom inside surface of each bowl, made from a non-galling bearing material, and configured to maintain the alignment of the rotating power transmission shaft in relation to the stationary bowl assembly.
Patent EP-4065449-A1 (EP)
Inventor: HORST ANDREW J
IPC: B62B7/06
Filed: 2020-11-26
Abstract: A child stroller apparatus (100) includes a rear (102) and a front leg frame (104) respectively having a first (112) and a second side segment (114), a handle frame (106) having a grip portion (118) and a third side segment (116) respectively connected fixedly with a first (162) and a second joining part (164) that are pivotally connected with each other, a latching mechanism (141) for locking the rear and front leg frames and the handle frame in an unfolded state, and a latch (170) carried with the third side segment. The latch can engage and disengage the first joining part to lock and unlock the grip portion relative to the third side segment. Moreover, a linking part (176) couples the latch (170) to the rear leg frame (102) or the front leg frame(104) so that a folding rotation of the handle frame (106) relative to the rear leg frame causes the latch (170) to disengage from the first joining part.
Patent EP-4070464-A1 (EP)
Inventor: YOUSEFBEIKI MOHSEN
IPC: H04B1/38
Filed: 2020-12-04
Abstract: The present invention discloses an improved a glazing unit extending along a plane, P, defined by a longitudinal axis, X, and a vertical axis, Z; having a width, DW, measured along the longitudinal axis, X, and a length, DL, measured along the vertical axis, Z, comprising, at least a first outer glass panel (11) having a S11 surface and a S12 surface and a second inner glass panel (12) having a S21 surface and a S22 surface combined together by at least a means (13) of maintaining the two glass panels at a certain distance between the surface S12 of the first outer glass panel and the surface S21 of the second inner glass sheet. The glazing unit also comprises a housing able to accommodate a 4G and/or 5G communication device and further comprises an opening arranged on the second inner glass panel, the housing been placed in the said opening.
Patent EP-3985477-A1 (EP)
Inventor: KATAYAMA TAKUYA
IPC: G05G1/32
Filed: 2020-04-13
Abstract: Provided is a vehicular operation pedal device having a fail-safe function to prevent backward movement of a step portion of an operation pedal mechanism at the time of a vehicle collision. A brake pedal device (1) includes a protrusion (90) which performs rotation restriction for preventing a rotating member (50) from rotating about a rotating shaft portion (14), and on which a restricting load (F2) acts by the rotation restriction. During the rotation restriction by the protrusion (90), a second load acts as the restricting load (F2) when a step portion (24) of an operation pedal mechanism (20) is fully stepped forward of a vehicle, and when the restricting load (F2) is greater than the second load, the rotation restriction is released due to deformation of the protrusion (90) by shearing or bending.
Patent EP-3983008-A1 (EP)
Inventor: HOMAN JANE
IPC: A61K39/00
Filed: 2020-06-11
Abstract: This invention provides a method for maximizing the immune response to mutated tumor specific proteins, either by means of stimulation of dendritic cells or T cells  in vitro  followed by administration of these cells to a patient, or by means of administration of a neoantigen vaccine in which  de novo  peptides, or their encoding nucleic acids, have been designed to ensure an appropriate level of binding affinity to a particular cancer patient's MHC alleles. This invention further provides for modulating the immune response in an immunopathology other than cancer.
Patent EP-4264449-A1 (EP)
Inventor: MÁTRAY PÉTER
IPC: G06F16/27
Filed: 2020-12-19
Abstract: A healing procedure is disclosed for distributed database. A storage node locally stores metadata for a plurality of data items stored in the distributed database. The metadata includes, for each data item, an identifier associated with the data item and an associated replica location list indicating one or more storage nodes in the distributed database storing replicas of the data item. Responsive to a trigger indicating a fault in a second storage node, the storage node iterates over the metadata to identify compromised data items for which the first storage node is designated as a healing node and performs a healing procedure for each compromised data item where the first storage node is designated as the healing node.
Patent EP-3979508-A1 (EP)
Inventor: JIA YUHU
IPC: H04B1/38
Filed: 2020-06-19
Abstract: A display screen assembly, an antenna assembly, and an electronic device are provided according to the present disclosure. The display screen assembly includes a display screen body and a radio-wave transparent structure. The display screen body has a first transmittance to a radio frequency (RF) signal in a preset frequency band. The radio-wave transparent structure is carried on the display screen body and covers at least part of the display screen body. The display screen assembly has a second transmittance to the RF signal in the preset frequency band in a region corresponding to the radio-wave transparent structure, and the second transmittance is greater than the first transmittance. In the display screen assembly provided in the present disclosure, the radio-wave transparent structure is carried on the display screen body. The transmittance to the RF signal in the preset frequency band can be improved with aid of the radio-wave transparent structure. In case that the display screen assembly is applied to an electronic device, influence of the display screen assembly on radiation performance of an antenna module disposed inside the electronic device can be reduced, as such, communication performance of the electronic device can be improved.
Patent EP-3996788-A1 (EP)
Title: Medical tubes and connectors for breathing circuits
Inventor: HOLYOAKE BRUCE GORDON
IPC: A61M16/08
Filed: 2020-07-08
Abstract: Disclosed is a connector for a medical tube, the connector having a first portion having a first opening, a second portion having a second opening, a lumen formed by the first portion and the second portion, the lumen providing a gases flow path between the first opening and the second opening, the first portion of the connector comprises at least one sensor port, the sensor port extending, through a wall of the first portion of the connector into the lumen, the second portion of the connector body may have at least one electrical port, the electrical port configured to provide for electrical connection with at least one wire of the medical tube, and the electrical port is located on the top of the second portion of the connector the first portion is angled with respect to the second portion to form an elbow.